COMMUNIQUÉS West-GlobeNewswire

EmblemHealth Expands Community Diabetes Wellness Program, Bringing Free, Citywide Support to New Yorkers
22/04/2026
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- EmblemHealth, one of the nation’s largest not-for-profit health plans, today announced the citywide expansion of its Community Diabetes Wellness Program . Originally launched [...]
BBOT Announces the Appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman
22/04/2026
Pedro J. Beltran, PhD, a seasoned executive who previously served as Chief Scientific Officer of BBOT, will assume the position of Chief Executive Officer, bringing his extensive drug development experience and [...]
LIfT BioSciences Announces Publication of Review Article in Frontiers in Immunology Highlighting Broad Therapeutic Potential of Neutrophils and IMANs in Cancer
22/04/2026
Neutrophils, long considered short-lived immune cells, can be therapeutically targeted when their appropriate subset and functional state are identified for the disease context LIfT BioSciences’ immunomodulatory alpha [...]
Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
22/04/2026
160-participant, triple-blinded, sham-controlled study designed to support planned De Novo FDA submission for moderate-to-severe insomnia HOUSTON, TX, April 22, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq [...]
Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning
22/04/2026
April 22, 2026 Clearances for Rembra CT, Rembra RT, and Areta RT enable high-throughput imaging at scale and elevate precision across the cancer care pathway Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: [...]
Amae Health and Novant Health bring enhanced integrated care model for severe mental illness to Charlotte, North Carolina
22/04/2026
The collaboration expands access to comprehensive outpatient behavioral health services for individuals with SMI in Mecklenburg County CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- Amae Health, a leader in [...]
PerfectServe Ranks #1 Across All Use Cases in the Gartner® Critical Capabilities for Clinical Communication and Collaboration Report
22/04/2026
Following recognition as highest in execution and furthest in vision in the 2026 Magic Quadrant™ for Clinical Communication and Collaboration MIAMI, April 22, 2026 (GLOBE NEWSWIRE) -- PerfectServe®, a leading provider [...]
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
22/04/2026
Expanding commercialization of first-line fertility treatment in the OB/GYN office to increase patient access ATLANTA, April 22, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator [...]
Three-Peat: Becker’s Healthcare Dubs U.S. Oral Surgery Management a DSO to Know
22/04/2026
IRVING, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- For the third year in a row, Becker’s Healthcare has named U.S. Oral Surgery Management ( USOSM ) to its annual DSOs to Know list. Honorees are selected by Becker’s, [...]
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
22/04/2026
SAN DIEGO, April 22, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced the [...]
Eleos Expands AI Agents Across the Full Care Journey
22/04/2026
New capabilities support provider decision-making, resolve eligibility gaps, and surface compliance risks the moment they can change outcomes DENVER and BOSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Eleos, the system of [...]
NETRIS Pharma: Nature publishes positive pancreatic cancer Phase 1b data for NP137 anti-netrin-1 monoclonal antibody
22/04/2026
LAPNET-01 Phase 1b study shows netrin-1 blockade may overcome and prevent chemoresistance in patients with pancreatic ductal adenocarcinoma (PDAC) with locally advanced PDAC (LAPC) NP137 is the first-in-class anti- [...]
Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial
22/04/2026
Demonstration batch production achieves all prespecified test specifications for dissolution, content uniformity, blend uniformity meeting regulatory requirements to start clinical drug product production GLEN ALLEN, Va [...]
OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records
22/04/2026
Searchable in Seconds Powered by Palantir Foundry MINNEAPOLIS, April 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of [...]
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
22/04/2026
AUSTIN, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : The biotechnology industry is experiencing a subtle yet meaningful transformation that is redefining how value is interpreted within a [...]
Mixlab and Instinct Partner to Transform Prescription Workflows for Veterinary Hospitals
22/04/2026
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- As veterinary hospitals manage growing clinical complexity and administrative demands, workflow efficiency remains a key priority for both patient outcomes and team [...]
SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital
22/04/2026
Company has invested greater than 10% of its investable capital in the convergence of Artificial Intelligence (“AI”) and space through Astro Capital NORTH PALM BEACH, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- SRx Health [...]
Aclarion Announces $2.5 Million Stock Repurchase Plan
22/04/2026
Highlights Disciplined Capital Allocation While Supporting Continued Nociscan® Adoption BROOMFIELD, Colo., April 22, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc ., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a [...]
Outlook Therapeutics Announces $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
22/04/2026
ISELIN, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics” or the “Company”), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab [...]

Pages